New gene-editing therapy shows early success in fighting advanced GI cancers
med.umn.edu
Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results, recently published in Lancet Oncology, show encouraging signs of safety and potential effectiveness of the treatment.
  • manxu@piefed.socialEnglish
    3·
    10 days ago

    I have seen enough loved ones affected by GI cancer, the only bad thing about this news is that it didn’t come ten years ago!